We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02653209
Brief Title: TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes. (TriMaster)

First Submitted : January 8, 2016
First Submitted that Met QC Criteria : January 8, 2016
First Posted : January 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 30, 2021
Last Update Posted : April 1, 2021